Literature DB >> 27576431

Image-guided radiotherapy for prostate cancer with cone beam CT: dosimetric effects of imaging frequency and PTV margin.

Hemal Ariyaratne1, Hayley Chesham2, John Pettingell3, Roberto Alonzi4.   

Abstract

BACKGROUND AND
PURPOSE: This study assesses the effect of frequency of cone beam CT (CBCT) verification imaging on dose-volume parameters during image-guided radiotherapy (IGRT) for prostate cancer. It also investigates the dosimetric impact of reducing the planning target volume (PTV) margin, when daily imaging is used.
MATERIAL AND METHODS: 844 CBCT images from 20 patients undergoing radical prostate radiotherapy were included. Patients received a dose of 74Gy in 37 fractions using 7-field intensity-modulated radiotherapy (IMRT). Clinical target volume (CTV) and organs at risk were contoured manually on each slice of every CBCT image. A daily online CBCT verification schedule was compared with a protocol of verification on days 1-3 followed by weekly online imaging. PTV margins of 3mm, 5mm, and 7mm were compared for the daily imaging protocol.
RESULTS: 90% of patients had improved target coverage with daily online in comparison to weekly online imaging. A median of 37 fractions per treatment course achieved CTV coverage with daily imaging compared to 34 fractions with a weekly online protocol. 80% of patients had a reduction in rectal dose with the daily protocol. PTV margin reduction to 5mm with adequate target coverage was feasible with daily imaging.
CONCLUSIONS: Daily online CBCT verification improves CTV coverage and reduces rectal dose during IGRT for prostate cancer. Tighter PTV margins could be considered with daily CBCT use.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cone beam CT; Image-guided radiotherapy; PTV margin; Prostate cancer; Verification imaging

Mesh:

Year:  2016        PMID: 27576431     DOI: 10.1016/j.radonc.2016.07.018

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  17 in total

Review 1.  Robustness Analysis for External Beam Radiation Therapy Treatment Plans: Describing Uncertainty Scenarios and Reporting Their Dosimetric Consequences.

Authors:  Adam D Yock; Radhe Mohan; Stella Flampouri; Walter Bosch; Paige A Taylor; David Gladstone; Siyong Kim; Jason Sohn; Robert Wallace; Ying Xiao; Jeff Buchsbaum
Journal:  Pract Radiat Oncol       Date:  2018-12-15

2.  Acute Toxicity in Hypofractionated/Stereotactic Prostate Radiotherapy of Elderly Patients: Use of the Image-guided Radio Therapy (IGRT) Clarity System.

Authors:  Rossella DI Franco; Valentina Borzillo; Domingo Alberti; Gianluca Ametrano; Angela Petito; Andrea Coppolaro; Ilaria Tarantino; Sabrina Rossetti; Sandro Pignata; Gelsomina Iovane; Sisto Perdonà; Giuseppe Quarto; Giovanni Grimaldi; Alessandro Izzo; Luigi Castaldo; Raffaele Muscariello; Marcello Serra; Gaetano Facchini; Paolo Muto
Journal:  In Vivo       Date:  2021 May-Jun       Impact factor: 2.155

3.  Image registration assessment in radiotherapy image guidance based on control chart monitoring.

Authors:  Wenyao Xia; Stephen L Breen
Journal:  J Med Imaging (Bellingham)       Date:  2018-03-14

Review 4.  Proton therapy for prostate cancer: current state and future perspectives.

Authors:  Yao-Yu Wu; Kang-Hsing Fan
Journal:  Br J Radiol       Date:  2021-09-24       Impact factor: 3.039

5.  Bowel and Bladder Reproducibility in Image Guided Radiation Therapy for Prostate Cancer: Results of a Patterns of Practice Survey.

Authors:  Lindsay S Rowe; Jeremy J Mandia; Kilian E Salerno; Uma T Shankavaram; Shaoli Das; Freddy E Escorcia; Holly Ning; Deborah E Citrin
Journal:  Adv Radiat Oncol       Date:  2022-02-03

6.  Prostate external beam radiotherapy combined with high-dose-rate brachytherapy: dose-volume parameters from deformably-registered plans correlate with late gastrointestinal complications.

Authors:  Calyn R Moulton; Michael J House; Victoria Lye; Colin I Tang; Michele Krawiec; David J Joseph; James W Denham; Martin A Ebert
Journal:  Radiat Oncol       Date:  2016-10-31       Impact factor: 3.481

7.  Influence of daily imaging on plan quality and normal tissue toxicity for prostate cancer radiotherapy.

Authors:  Katharina Bell; Marina Heitfeld; Norbert Licht; Christian Rübe; Yvonne Dzierma
Journal:  Radiat Oncol       Date:  2017-01-10       Impact factor: 3.481

8.  Analyses of the factors influencing the accuracy of three-dimensional ultrasound in comparison with cone-beam CT in image-guided radiotherapy for prostate cancer with or without pelvic lymph node irradiation.

Authors:  Sha Zhou; Liling Luo; Jibin Li; Maosheng Lin; Li Chen; Jianhui Shao; Shipei Lu; Yaru Ma; Yingting Zhang; Wenfen Chen; Mengzhong Liu; Shiliang Liu; Liru He
Journal:  Radiat Oncol       Date:  2019-01-29       Impact factor: 3.481

9.  Evaluation of patient organ doses from kilovoltage cone-beam CT imaging in radiation therapy.

Authors:  Alper Özseven; Bahar Dirican
Journal:  Rep Pract Oncol Radiother       Date:  2021-04-14

10.  Outcomes and toxicity from a prospective study of moderately hypofractionated radiation therapy for prostate cancer.

Authors:  Wei Gang Wang; Di Yan; Hong Ye; Gary Gustafson; Michael Ghilezan; Alvaro Martinez; Daniel Krauss
Journal:  Adv Radiat Oncol       Date:  2017-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.